Drug recall · August 26, 2015
Gemcitabine for Injection recall
Why: Presence of Particulate Matter
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Gemcitabine for Injection, USP, 1 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-462-01, UPC 3 67457 46201 1.
- Lots / codes
Lot #: 7801273, 7801284, Exp 05/16
- Quantity
- 10,094 vials
- Company
- Mylan Institutional LLC, Rockford, IL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- March 23, 2015 · Voluntary: Firm initiated
- Classified
- August 14, 2015
- Reported
- August 26, 2015
- Ended
- May 20, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gemcitabine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.